P M O'Connor

7.4k citations
38 papers · 5.4k · 3 hit papers · h-index 29

Impact in

  • Oncology top 0.5%
    • Cancer-related Molecular Pathways
  • Biotechnology top 0.5%
    • Cancer Research and Treatments

Papers in

    • Cancer-related Molecular Pathways 27
    • DNA Repair Mechanisms 9
    • Epigenetics and DNA Methylation 6
    • Ubiquitin and proteasome pathways 4
    • RNA modifications and cancer 4
    • Cancer therapeutics and mechanisms 3

P M O'Connor

38 papers receiving 5.3k citations

P M O'Connor's Hit Papers

GADD45 induction of a G 2 /M cell cycle checkpoint 1999 · 539 citations
5390+10+21Years since publication250500750

Peers

P M O'Connor
Comparison fields: 5 of 106
  • Oncology 3.0k
  • Biotechnology 510
  • Cancer Research 794
  • Molecular Biology 3.6k
  • Cell Biology 776
Replace James J. Manfredi with:
James J. Manfredi United States
Sheau-Yann Shieh Taiwan
Christine E. Canman United States
Gen Sheng Wu United States
Adly Yacoub United States
Jill Bargonetti United States
Lee Ann Remington United States
Ruth Maya Israel
Galina Selivanova Sweden
Andrei L. Gartel United States
P M O'Connor relative to James J. Manfredi United States James J. Manfredi's profile →
Citations per field
00.5×1.5×
James J. Manfredi · 1×
Citations per year

Countries citing papers authored by P M O'Connor

Since Specialization
Citations

This map shows the geographic impact of P M O'Connor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P M O'Connor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P M O'Connor more than expected).

Fields of papers citing papers by P M O'Connor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P M O'Connor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P M O'Connor. The network helps show where P M O'Connor may publish in the future.

Co-authors

The 25 scholars most cited alongside P M O'Connor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with P M O'Connor Line = papers co-authored together P M O'Connor links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents.
Hit paper breakdown →
1997760
2
GADD45 induction of a G 2 /M cell cycle checkpoint
Hit paper breakdown →
1999539
3 1997457
4 1996370
5
p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents.
Hit paper breakdown →
1994358
6
Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage.
1995320
7
Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines.
1993286
8 2010240
9 1995213
10
Abrogation of an S-phase checkpoint and potentiation of camptothecin cytotoxicity by 7-hydroxystaurosporine (UCN-01) in human cancer cell lines, possibly influenced by p53 function.
1997206
11 1995149
12 1993145
13
Unscheduled activation of cyclin B1/Cdc2 kinase in human promyelocytic leukemia cell line HL60 cells undergoing apoptosis induced by DNA damage.
1995143
14 1997131
15 199496
16
Relationships between G1 arrest and stability of the p53 and p21Cip1/Waf1 proteins following gamma-irradiation of human lymphoma cells.
199596
17 199887
18 199485
19
Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
199679
20
Disruption of p53 function in immortalized human cells does not affect survival or apoptosis after taxol or vincristine treatment.
199872

About P M O'Connor

P M O'Connor is a scholar working on Oncology, Molecular Biology, Cell Biology, Biotechnology and Cancer Research, having authored 38 papers that have together received 5.4k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (27 papers), DNA Repair Mechanisms (9 papers), Microtubule and mitosis dynamics (9 papers), Epigenetics and DNA Methylation (6 papers), Cancer Research and Treatments (5 papers), Ubiquitin and proteasome pathways (4 papers), RNA modifications and cancer (4 papers) and Cancer therapeutics and mechanisms (3 papers). The work is most often cited by research in Oncology (3.0k citations), Biotechnology (510 citations), Cancer Research (794 citations), Molecular Biology (3.6k citations) and Cell Biology (776 citations). P M O'Connor has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Kurt W. Kohn, Albert J. Fornace, Saijun Fan, Joany Jackman, Edward A. Sausville, Kishor Bhatia, Ian Magrath, I Bae, Martin L. Smith and Michele Fiscella. Their work appears in journals such as Journal of Biological Chemistry, Proceedings of the National Academy of Sciences, Molecular Cancer Therapeutics, Biochemical and Biophysical Research Communications and Carcinogenesis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact